Common conditions include: Relapsing Multiple Sclerosis (RMS), Tumefactive Multiple Sclerosis
Lauren Krupp is a Neurologist in New York, New York. Krupp has been practicing medicine for over 42 years and is rated as an Elite expert by MediFind in the treatment of Multiple Sclerosis (MS). She is also highly rated in 7 other conditions, according to our data. Her top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), CACH Syndrome, and Optic Neuritis. Krupp is currently accepting new patients.
Laura Balcer is a Neurologist in New York, New York. Balcer has been practicing medicine for over 32 years and is rated as an Elite expert by MediFind in the treatment of Multiple Sclerosis (MS). She is also highly rated in 14 other conditions, according to our data. Her top areas of expertise are Optic Neuritis, Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), and Concussion. Balcer is currently accepting new patients.
Jeffrey Cohen is a Neurologist in Cleveland, Ohio. Cohen has been practicing medicine for over 43 years and is rated as an Elite expert by MediFind in the treatment of Multiple Sclerosis (MS). He is also highly rated in 8 other conditions, according to our data. His top areas of expertise are Relapsing Multiple Sclerosis (RMS), Multiple Sclerosis (MS), Neuromyelitis Optica, and Optic Neuritis. Cohen is currently accepting new patients.
Summary: This study will evaluate the pharmacokinetics, pharmacodynamics, safety, immunogenicity, and radiological and clinical effects of subcutaneous (SC) administration of ocrelizumab compared with the intravenous (IV) infusion of ocrelizumab in patients with either relapsing multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS).
Summary: This extension study will evaluate the effectiveness and safety of ocrelizumab in multiple sclerosis (MS) participants who were previously enrolled in a F. Hoffmann-La Roche (Roche) sponsored ocrelizumab phase IIIb/IV trial (i.e. the Parent, P-trial).